Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02927691 · ClinicalTrials.gov registry record · Phase 2
Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial
A Phase 2 study, sponsored by Teachers College, Columbia University.
- Completed
- Registry status
- Phase 2
- Development phase
- 65
- Enrollment target
NCT02927691: Completed Phase 2 study, sponsored by Teachers College, Columbia University.
NCT02927691 is a Phase 2 study that has completed, run by Teachers College, Columbia University. The registered enrollment target is 65 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (51% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02927691, a Phase 2 study, has completed, sponsored by Teachers College, Columbia University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 65 participants
- Enrollment target
Study Summary
Currently, there are no efficacious behavioral treatment approaches to address uncompensated aspiration, or aspiration without appropriate cough response, in Parkinson's disease (PD). This is of particular public health concern given that aspiration pneumonia is the leading cause of death in persons with PD. The overarching aim of the proposed study is to determine the efficacy of two distinct intensive rehabilitation paradigms, expiratory muscle strength training (EMST) and sensorimotor treatment for airway protection (smTAP), on airway protective clinical outcomes in persons with PD and dysphagia. The investigators anticipate the results will lead to reductions in the risks associated with airway protective deficits.
Primary Outcome
Peak expiratory flow rate (PEFR) was measured before (baseline) and after 5 weeks of treatment with EMST and smTAP.
Interventions
- DEVICE EMST
- BEHAVIORAL smTAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2016-09 |
| Est. Completion | 2021-06 |
| Phase | Phase 2 |
What the finished NCT02927691 record still lists
NCT02927691 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (51% lower).
The record links to 0 conditions, and to 2 interventions - of which EMST is the first listed.
NCT02927691 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02927691 about?
NCT02927691 is a clinical study titled "Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial". Currently, there are no efficacious behavioral treatment approaches to address uncompensated aspiration, or aspiration without appropriate cough response, in Parkinson's disease (PD). This is of particular public health concern given that aspiration pneumonia is the leading cause of death in persons...
What is the current status of trial NCT02927691?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 65 participants. The study started on 2016-09. Estimated completion is 2021-06.
What interventions are being tested in trial NCT02927691?
The interventions under investigation include: EMST (DEVICE), smTAP (BEHAVIORAL).
Who is sponsoring clinical trial NCT02927691?
This trial is sponsored by Teachers College, Columbia University, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02927691's enrollment target sits among peer trials
65 987th of 2000 higher than 1,005 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia